March 16, 2021   NEWS

Analysts call $310 CSL target price in new report

SYDNEY: Biotech company CSL was upgraded to ‘buy’ by analysts at Citi Group ...

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In